Cargando…
Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model
BACKGROUND: Interleukin-24 (IL-24) is a therapeutic gene for melanoma, which can induce melanoma cell apoptosis. Mesenchymal stem cells (MSCs) show promise as a carrier to delivery anti-cancer factors to tumor tissues. Induced pluripotent stem cells (iPSCs) are an alternative source of mesenchymal s...
Autores principales: | Wu, Zheng, Liu, Wei, Wang, Zujia, Zeng, Baitao, Peng, Guangnan, Niu, Hongyan, Chen, Linlin, Liu, Cong, Hu, Qian, Zhang, Yuxuan, Pan, Mengmeng, Wu, Lingqian, Liu, Mujun, Liu, Xionghao, Liang, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990536/ https://www.ncbi.nlm.nih.gov/pubmed/32015693 http://dx.doi.org/10.1186/s12935-020-1112-7 |
Ejemplares similares
-
Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci
por: Liu, Bo, et al.
Publicado: (2017) -
ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
por: Hu, Zhiqing, et al.
Publicado: (2019) -
IL-24 armored CAR19-T cells show enhanced antitumor activity and persistence
por: Hu, Qian, et al.
Publicado: (2021) -
Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes
por: Xiao, Rou, et al.
Publicado: (2022) -
Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
por: Wang, Zujia, et al.
Publicado: (2022)